Gizem Kaya

Glucagon-like peptide-1 receptor agonist (GLP-1RAs) and more recently Twin-Cretins (GLP+GIP) are frequently used for patients with diabetes and associated obesity. In part their use is increasing based on the recommendation by the ADA and the EASD due to associated comorbidities…